KEVIN F MCLAUGHLIN
CIK 1214938 · SVP, CFO and Treasurer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$724.0K
Companies
5
Total Filings
82
Lifetime Open-Market Net
-$30.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IVVD | Director | 50,000 | $0.77 | $38.5K | $125.0K | 4 | 2026-05-21 |
| VCEL | Director | 18,300 | $37.46 | $685.5K | -$2.37M | 21 | 2026-05-15 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | 0 | $4.91 | $0 | $0 | 3 | 2023-09-25 |
| ACCELERON PHARMA INC (XLRN) Delisted | SVP, CFO and Treasurer | 0 | $178.75 | $0 | -$28.26M | 53 | 2021-11-22 |
| PRCS | President and CEO | 0 | $27.74 | $0 | $0 | 1 | 2007-02-08 |
Recent Filings · Page 9 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-12-09 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-02-08 | PRCS | Mixed | −45,000 | -$225.0K | EDGAR |
Showing 81–82 of 82
Prev
Page 9 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.